| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 122,122 | 103,898 | 78,050 | 87,140 | | Cost of Revenue | 84,547 | 76,528 | 63,557 | 64,264 | | | Gross Profit | 37,575 | 27,370 | 14,493 | 22,876 | | | Operating Expenses | | Research Development | 6,284 | 5,385 | 5,275 | 5,792 | | Selling General and Administrative | 19,079 | 15,240 | 16,056 | 15,718 | | Non Recurring | (291) | (248) | 99 | 4,089 | | Others | 7,742 | 1,118 | 1,091 | 2,123 | | | | Total Operating Expenses | 32,814 | 21,495 | 22,521 | 27,722 | | | | Operating Income or Loss | 11,232 | 5,875 | (8,028) | (4,846) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 817 | 1,070 | 2,020 | 21,153 | | Earnings Before Interest And Taxes | 4,504 | 6,945 | (6,008) | 16,307 | | Interest Expense | (2,706) | 4,158 | 4,257 | 2,074 | | Income Before Tax | 7,210 | 2,787 | (10,265) | 14,233 | | Income Tax Expense | (629) | 5,156 | 397 | (730) | | Minority Interest | (819) | (688) |
-
| (352) | | | | Net Income From Continuing Ops | 7,020 | (3,057) | (10,662) | 14,611 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,020 | (3,057) | (10,662) | 14,611 | | Preferred Stock And Other Adjustments |
-
| 104 | (104) |
-
| | | Net Income Applicable To Common Shares | $7,020 | ($2,953) | ($10,766) | $14,611 |
|
1.52% Nasdaq 0.00%
Income Statement
